Pancreatic lipase inhibitory activity of selected pharmaceutical agents
Twenty-five structurally diverse compounds have been tested in vitro for their pancreatic lipase (PL) inhibitory activity. Despite the diversity of tested compounds, the relationship comprising structural attributes of the compounds could be established to correlate with the observed inhibitory acti...
Main Authors: | Hamdan Imad I., Kasabri Violet N., Al-Hiari Yusuf M., El-Sabawi Dina, Zalloum Hiba |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2019-03-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2019-0010 |
Similar Items
-
Inhibitory effect of astaxanthin on pancreatic lipase with inhibition kinetics integrating molecular docking simulation
by: Xiping Du, et al.
Published: (2018-09-01) -
Novel angiotensin-converting enzyme and pancreatic lipase oligopeptide inhibitors from fermented rice bran
by: Jingfei Hu, et al.
Published: (2022-09-01) -
Lipase activity in the human aorta
by: Kiyoshi Hayase, et al.
Published: (1970-05-01) -
Exploring Aurone Derivatives as Potential Human Pancreatic Lipase Inhibitors through Molecular Docking and Molecular Dynamics Simulations
by: Phuong Thuy Viet Nguyen, et al.
Published: (2020-10-01) -
Role of amylase and lipase in diagnosis of acute pancreatitis
by: Lavanya, et al.
Published: (2018-01-01)